Prices delayed by at least 15 minutes | Print
bluebird bio (BLUE)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Address
60 Binney Street
Cambridge
MA
USA
02142
Telephone
+1 339 4999300
Forecast key dates
Name | Key Date |
---|---|
bluebird bio Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-03-26T08:00:00 |
bluebird bio Inc Fourth Quarter Earnings Results for 2024 | 2025-03-26T00:00:00 |
bluebird bio Inc Third Quarter Earnings Conference Call for 2024 | 2024-11-07T08:00:00 |
bluebird bio Inc Third Quarter Earnings Results for 2024 | 2024-11-07T00:00:00 |
bluebird bio Inc Second Quarter Earnings Conference Call for 2024 | 2024-08-08T08:00:00 |
bluebird bio Inc Second Quarter Earnings Results for 2024 | 2024-08-08T00:00:00 |
bluebird bio Inc Annual General Meeting for 2024 | 2024-06-14T08:30:00 |
bluebird bio Inc First Quarter Earnings Results for 2024 | 2024-05-09T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
bluebird bio Inc First Quarter Earnings Results for 2024 | 2024-05-09T00:00:00 |
bluebird bio Inc Annual Report for 2023 | 2024-04-26T00:00:00 |
bluebird bio Inc Fourth Quarter Earnings Conference Call for 2023 | 2024-03-26T08:00:00 |
bluebird bio Inc Fourth Quarter Earnings Result for 2023 | 2024-03-26T00:00:00 |
LYFGENIA™ FDA Approved | 2023-12-08T16:15:00 |
bluebird bio Inc Third Quarter Earnings Conference Call for 2023 | 2023-11-07T08:00:00 |
bluebird bio Inc Third Quarter Earnings Result for 2023 | 2023-11-07T00:00:00 |
bluebird bio Inc Second Quarter Earnings Conference Call for 2023 | 2023-08-08T08:00:00 |
bluebird bio Inc Second Quarter Earnings Result for 2023 | 2023-08-08T00:00:00 |
bluebird bio Inc Annual General Meeting for 2023 | 2023-06-16T08:30:00 |
bluebird bio Inc First Quarter Earnings Results for 2023 | 2023-05-09T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.